New York, NY, October 6, 2019 —
TAK-079
A Study to Evaluate the Safety of TAK-079
PAISLEY-SLE
A Phase II study to evaluate a novel, oral therapy in SLE
ORKIDS
A study to evaluate the effects of krill oil in SLE
LOTUS
A Phase III study to evaluate Stelara® in SLE
DIVINE
A study to evaluate a novel imaging procedure to access Lupus Nephritis (LN)
RIFLE
A study to evaluate delayed-released Prednisone
IBERDOMIDE
A Phase II study to evaluate a novel, small-molecule therapy
BMS-986165
An investigational study to evaluate BMS-986165 for Lupus Nephritis
EVOBRUTINIB
A Phase II study to evaluate a novel inhibitor in SLE
AMG 570
A Phase II study to evaluate AMG 570 for SLE
